首页> 美国卫生研究院文献>Oncotarget >Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells
【2h】

Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells

机译:靶向MUC1-C癌蛋白可抑制乳腺癌细胞的自我更新能力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The capacity of breast cancer cells to form mammospheres in non-adherent serum-free culture is used as a functional characteristic of the self-renewing stem-like cell population. The present studies demonstrate that silencing expression of the MUC1-C oncoprotein inhibits growth of luminal MCF-7 and HER2-overexpressing SKBR3 breast cancer cells as mammospheres. We also show that triple-negative MDA-MB-468 breast cancer cells are dependent on MUC1-C for growth as mammospheres and tumor xenografts. Similar results were obtained when MUC1-C function was inhibited by expression of a MUC1-C(CQC→AQA) mutant. Moreover, treatment with the MUC1-C inhibitor GO-203, a cell penetrating peptide that binds to the MUC1-C cytoplasmic domain and blocks MUC1-C function, confirmed the importance of this target for self-renewal. The mechanistic basis for these findings is supported by the demonstration that MUC1-C activates NF-κB, occupies the IL-8 promoter with NF-κB, and induces IL-8 transcription. MUC1-C also induces NF-κB-dependent expression of the IL-8 receptor, CXCR1. In concert with these results, targeting MUC1-C with GO-203 suppresses IL-8/CXCR1 expression and disrupts the formation of established mammospheres. Our findings indicate that MUC1-C contributes to the self-renewal of breast cancer cells by activating the NF-κB→IL-8/CXCR1 pathway and that targeting MUC1-C represents a potential approach for the treatment of this population.
机译:乳腺癌细胞在非粘附无血清培养物中形成乳球的能力被用作自我更新的干细胞样细胞群的功能特征。本研究表明,MUC1-C癌蛋白的沉默表达抑制了腔内MCF-7和过表达HER2的SKBR3乳腺癌细胞的生长。我们还显示,三阴性MDA-MB-468乳腺癌细胞依赖MUC1-C作为乳球和肿瘤异种移植物生长。当MUC1-C(CQC→AQA)突变体的表达抑制了MUC1-C功能时,获得了相似的结果。此外,用MUC1-C抑制剂GO-203(一种与MUC1-C胞质域结合并阻断MUC1-C功能的细胞穿透肽)进行治疗,证实了该靶标对于自我更新的重要性。这些发现的机制基础得到了MUC1-C激活NF-κB,占据NF-κB的IL-8启动子并诱导IL-8转录的证明的支持。 MUC1-C还诱导IL-8受体CXCR1依赖NF-κB的表达。与这些结果一致,用GO-203靶向MUC1-C可抑制IL-8 / CXCR1表达并破坏已建立的乳球的形成。我们的发现表明,MUC1-C通过激活NF-κB→IL-8 / CXCR1途径而有助于乳腺癌细胞的自我更新,而靶向MUC1-C代表了治疗该人群的潜在方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号